Kronos Bio Expands Scientific Advisory Board with Addition of Roger D. Kornberg, Ph.D.
9 August 2019 - - US-based Kronos Bio, Inc., a Two River portfolio company, has appointed Roger D. Kornberg, Ph.D., to its scientific advisory board, the company said.

Dr. Kornberg, a renowned biochemist, is Winzer Professor in Medicine in the Department of Structural Biology at Stanford University School of Medicine. He was awarded the Nobel Prize in Chemistry in 2006 for his studies of the molecular basis of eukaryotic transcription, the process by which DNA is copied to RNA.

Dr. Kornberg has been a member of the faculty of Stanford University since 1972. Prior to that, he was a professor at Harvard Medical School.

He was elected to the National Academy of Sciences in 1993 and is the recipient of several awards, including the 2001 Welch Prize, the highest award granted in the field of chemistry in the United States, and the 2002 Leopold Mayer Prize, the highest award granted in the field of biomedical sciences from the French Academy of Sciences.

He earned a B.S. in chemistry from Harvard University and a Ph.D. in chemistry from Stanford University. He was a postdoctoral fellow and member of the scientific staff at the Laboratory of Molecular Biology in Cambridge, England, where he discovered the nucleosome, the basic unit of DNA coiling in chromosomes.

Dr. Kornberg holds honorary degrees from universities in Europe and Israel, including the Hebrew University in Jerusalem, where he is currently a visiting professor.

Kronos Bio is focused the discovery and development of first-in-class therapies that modulate historically undruggable targets.